Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafenoquine vs Primaquine for Radical Cure of P. vivax Malaria
NCT04411836Phase 3Completed
- Sponsor
- Menzies School of Health Research
- Start
- Apr 2021
- Primary completion
- Sep 2024
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of tafenoquine in Plasmodium vivax malaria, sponsored by Menzies School of Health Research. Started Apr 2021; status: completed.
02
Drugs
tafenoquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT04411836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411836.